A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

NCT00230815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DEVICE: Follitropin alfa injected by Pen device
DEVICE: Recombinant Human Choriogonadotropin (r-hCG)

Sponsor

EMD Serono